iRhythm Technologies, Inc. IRTC
iRhythm Technologies, Inc. (Nasdaq: IRTC) is a cardio-renal-metabolic medical device company.
Upcoming catalysts
No catalyst is dated to the next 30 days or to an FDA action date.
Pipeline
| Program | Indication | Modality | Stage |
|---|---|---|---|
| iRhythm ACM System (Zio XT) | ambulatory cardiac monitoring | device-combination | Approved |
| iRhythm ACM System (Zio monitor, Zio AT) | ambulatory cardiac monitoring | device-combination | Approved |
| VitalConnect VitalPatch | patient monitoring (ambulatory and inpatient cardiac monitoring) | device-combination | Approved |
Recent results and decisions
- Nov 5, 2026submitted iRhythm submitted FDA 510(k) applications for pediatric use with Zio Monitor long-term continuous monitoring business.
Submitted FDA 510(k) applications for pediatric use with our Zio Monitor long-term continuous monitoring business
Filing
For subscribers
- Cash runway against each catalyst, with the company's own runway statement
- Track record: every Phase 3 readout, FDA decision and guidance slip since 2014
- Expected move for each dated catalyst, from comparable past events
- Phase 2 evidence behind each Phase 3 readout
- Companies on the same target or class
- Full catalyst list with filing sentences, deals, registered trials, Excel export
Other cardio-renal-metabolic companies
The free Monday brief
Last week's readouts and FDA decisions and the dated catalysts in the week ahead, each with its filing sentence.